Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Mabwell Receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711 2024-02-20 22:00
FDA Grants Orphan Drug Designation to 9MW3011 2024-02-20 22:00
Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase 2024-01-02 17:15
New Drug Application of Mabwell's 8MW0511 for Injection Accepted by NMPA 2023-12-19 20:00
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial 2023-12-11 20:00
Good Safety Profile and Antitumor Activity: Oral Presentation of Mabwell's 9MW2821 at 2023 ESMO 2023-10-25 17:46
Mabwell Announces Latest Clinical Progress and Data to be Reported on ESMO 2023 of 2 Novel Drugs 2023-10-23 18:25
FDA Grants Fast Track Designation to 9MW3011 2023-09-22 08:00
Mabwell and WuXi XDC Sign Long-Term ADC Strategic Collaboration to Accelerate Global Layout of Innovative Biologics 2023-09-08 15:30
Mabwell to Present Clinical Trial Data of 2 Programs at ESMO Congress 2023 2023-07-26 00:00
Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND 2023-07-22 00:00
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND 2023-07-19 00:00
Mabwell Announces the U.S. FDA approval of 9MW3811 for IND 2023-06-15 21:00
Mabwell Publishes the Preclinical Study Results on Its Nectin-4 Targeting ADC in A Well-known AACR Journal 2023-06-15 21:00
China's First Nectin-4 Targeted ADC 9MW2821 Clinical Progress Released 2023-04-07 16:34
The World's Second Approved Biosimilars of Denosumab (MAILISHU) 2023-04-03 13:44
Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011 2023-03-14 23:42
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND 2023-02-28 23:00
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases 2023-01-20 09:50
Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries 2022-12-20 17:00
1 2 3